{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:15Z","timestamp":1789020435083,"version":"build-2803163510"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>People living with human immunodeficiency virus (HIV; PLHIV) have elevated risks of AIDS-defining cancers (ADCs), including cervical cancer, non-Hodgkin lymphoma (NHL), and Kaposi sarcoma (KS). Previous studies have quantified the individual global burden of these cancers, we aimed to estimate the pooled global burden of HIV-attributable and all-cause ADCs in 2022 and identify the key drivers across different regions and countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis to update risk ratios (RRs) for cervical cancer, NHL, and KS. RRs were used to calculate population-attributable fractions (PAFs) and age-standardized incidence rates (ASIRs) of HIV-attributable ADCs using country-specific HIV prevalence and 2022 cancer incidence data. Associations with the Human Development Index (HDI) were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In 2022, an estimated 101,835 (95% CI 76102\u2013131,298) ADC cases were attributable to HIV, accounting for 8.1% (95% CI 6.2\u201310.4) of all-cause ADC cases. NHL comprised 62.9% of HIV-attributable ADCs, while cervical cancer accounted for 53.0% of all cases. The highest HIV-attributable ASIRs were in Eswatini (34.9%), Zambia (32.0%), and Mozambique (25.9%). In East and Southern Africa, 27.8% of ADCs were linked to HIV. Among 35 countries with high cancer burden and HIV attribution, 68.6% were in Africa. Lower HDI correlated with higher PAF (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f\u22120.27), all-cause ASIR (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f\u22120.25), and HIV-attributable ASIR (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f\u22120.28).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HIV significantly contributes to the global ADC burden. Addressing immunosuppression, viral co-infections, and healthcare access through ART expansion, oncogenic virus monitoring, and cancer prevention is essential to mitigate the dual burden of HIV and ADCs globally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1933709","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:49Z","timestamp":1789018309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimates of the global burden of HIV-attributable and all-cause AIDS-defining cancers: a population-based modeling study"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaojun","family":"Meng","sequence":"first","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Yang","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibiao","family":"Chen","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Yin","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuping","family":"Xu","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gu","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Ma","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Shen","sequence":"additional","affiliation":[{"name":"The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref1","year":"2026"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/CCO.0b013e328355e131","article-title":"HIV infection, aging, and immune function: implications for cancer risk and prevention","volume":"24","author":"Dubrow","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/COH.0000000000000327","article-title":"Evolving epidemiology of HIV-associated malignancies","volume":"12","author":"Shiels","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"ref4","first-page":"1","article-title":"Revised surveillance case definition for HIV infection--United States","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hernandez-Ramirez","year":"2017","journal-title":"Lancet HIV"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-9-1","article-title":"Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study","volume":"9","author":"Akarolo-Anthony","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e4850","DOI":"10.1097\/MD.0000000000004850","article-title":"HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India","volume":"95","author":"Godbole","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/QAD.0000000000000163","article-title":"Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States","volume":"28","author":"Robbins","year":"2014","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/jnci\/djae191","article-title":"Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019","volume":"116","author":"Trias-Llimos","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/infdis\/jis299","article-title":"Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in south African men and women","volume":"206","author":"Mbulawa","year":"2012","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"10358","DOI":"10.3390\/ijms251910358","article-title":"Entangled connections: HIV and HPV interplay in cervical Cancer-a comprehensive review","volume":"25","author":"Pavone","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"k3204","DOI":"10.1136\/bmj.k3204","article-title":"Non-Hodgkin lymphoma","volume":"362","author":"Bowzyk Al-Naeeb","year":"2018","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e000208","DOI":"10.1136\/jitc-2019-000208","article-title":"Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vdelta2(+) T cells activities after hematopoietic transplantation for blood malignancies","volume":"8","author":"Liu","year":"2020","journal-title":"J Immunother Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/BLCTT.S361320","article-title":"HIV\/AIDS associated lymphoma: review","volume":"12","author":"Berhan","year":"2022","journal-title":"Blood Lymphat Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"102370","DOI":"10.1016\/j.eclinm.2023.102370","article-title":"Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study","volume":"67","author":"Chen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.det.2019.05.008","article-title":"Kaposi Sarcoma Updates","volume":"37","author":"Etemad","year":"2019","journal-title":"Dermatol Clin"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hiv.12584","article-title":"The world-wide incidence of Kaposi's sarcoma in the HIV\/AIDS era","volume":"19","author":"Liu","year":"2018","journal-title":"HIV Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/cid\/cix480","article-title":"AIDS-defining Cancer project working group for IeDEA Cohere in EuroCoord. Comparison of Kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: a multiregional multicohort study","volume":"65","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/ijc.33951","article-title":"Burden of Kaposi sarcoma according to HIV status: a systematic review and global analysis","volume":"150","author":"Ibrahim Khalil","year":"2022","journal-title":"Int J Cancer"},{"key":"ref24","volume-title":"Global Cancer Observatory: Cancer Today (Version 1.1)","author":"Ferlay","year":"2024"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bjsports-2020-101977","article-title":"Methods matter: population attributable fraction (PAF) in sport and exercise medicine","volume":"54","author":"Khosravi","year":"2020","journal-title":"Br J Sports Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e1525","DOI":"10.1016\/S2214-109X(25)00264-5","article-title":"Global burden of cancer attributable to HIV: a worldwide incidence analysis","volume":"13","author":"Huang","year":"2025","journal-title":"Lancet Glob Health"},{"key":"ref27","year":"2024"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/01.cco.0000239882.23839.e5","article-title":"Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions","volume":"18","author":"Epeldegui","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood.V72.2.667.667","article-title":"Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma","volume":"72","author":"Subar","year":"1988","journal-title":"Blood"},{"key":"ref30","first-page":"1447","article-title":"Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago","volume":"342","author":"Manns","year":"1993","journal-title":"HTLV Lymphoma Study Group Lancet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical Cancer elimination initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e055470","DOI":"10.1136\/bmjopen-2021-055470","article-title":"Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the global burden of disease","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s13224-024-02052-x","article-title":"Cervical Cancer elimination. 90:70:90. Together we can","volume":"74","author":"Purandare","year":"2024","journal-title":"J Obstet Gynaecol India"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/S0140-6736(26)00410-1","article-title":"Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study","volume":"407","author":"Brisson","year":"2026","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1186\/s12885-024-12789-3","article-title":"Far behind 90-70-90's screening target: the prevalence and determinants of cervical cancer screening among sub-Saharan African women: evidence from demographic and health survey","volume":"24","author":"Hailegebireal","year":"2024","journal-title":"BMC Cancer"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"100436","DOI":"10.1016\/j.jcpo.2023.100436","article-title":"Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: a population-based survey","volume":"38","author":"Znaor","year":"2023","journal-title":"J Cancer Policy"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e26303","DOI":"10.1002\/jia2.26303","article-title":"Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey","volume":"27","author":"Asangbeh-Kerman","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3961\/jpmph.19.100","article-title":"The relationship between obesity, overweight, and the human development index in World Health Organization eastern Mediterranean region countries","volume":"53","author":"Ataey","year":"2020","journal-title":"J Prev Med Public Health"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ypmed.2011.02.017","article-title":"Worldwide prevalence of physical inactivity and its association with human development index in 76 countries","volume":"53","author":"Dumith","year":"2011","journal-title":"Prev Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/ijc.22762","article-title":"Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/1055-9965.EPI-14-1303","article-title":"Lifetime physical activity and the risk of non-Hodgkin lymphoma","volume":"24","author":"Boyle","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10552-009-9316-0","article-title":"Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes","volume":"20","author":"Goldman","year":"2009","journal-title":"Cancer Causes Control"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.3748\/wjg.v16.i26.3226","article-title":"Helicobacter pylori and gastric cancer in the Middle East: a new enigma?","volume":"16","author":"Hussein","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2018.00211","article-title":"Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"Muller","year":"2005","journal-title":"Ann Hematol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1093\/cid\/ciaf248","article-title":"Risk of Cancer in people with HIV experiencing varying degrees of immune recovery with sustained Virological suppression on antiretroviral treatment for more than 2 years: an international, multicenter","volume":"81","author":"Han","year":"2025","journal-title":"Observational Cohort Clin Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1445209","DOI":"10.3389\/fimmu.2024.1445209","article-title":"Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice","volume":"15","author":"Escalante","year":"2024","journal-title":"Front Immunol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1038\/s41467-024-49546-w","article-title":"A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection","volume":"15","author":"Zhong","year":"2024","journal-title":"Nat Commun"},{"key":"ref52","first-page":"2024","volume-title":"HIV Infection and Cancer Risk","year":"2026"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0010425","DOI":"10.1128\/mmbr.00104-25","article-title":"HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?","volume":"89","author":"Li","year":"2025","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","article-title":"Global, regional, and national burden of HIV\/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the global burden of disease study 2021","volume":"11","year":"2024","journal-title":"Lancet HIV"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e1001510","DOI":"10.1371\/journal.pmed.1001510","article-title":"Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE)","volume":"10","author":"Mocroft","year":"2013","journal-title":"PLoS Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10552-012-9924-y","article-title":"Commentary: eight ways to prevent cancer: a framework for effective prevention messages for the public","volume":"23","author":"Dart","year":"2012","journal-title":"Cancer Causes Control"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ajic.2014.06.029","article-title":"National HIV\/AIDS mortality, prevalence, and incidence rates are associated with the human development index","volume":"42","author":"Lou","year":"2014","journal-title":"Am J Infect Control"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4314\/ahs.v13i2.15","article-title":"Factors affecting the HIV\/AIDS epidemic: an ecological analysis of global data","volume":"13","author":"Mondal","year":"2013","journal-title":"Afr Health Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10147-021-02108-2","article-title":"Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050","volume":"27","author":"Sharma","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7326\/M16-2094","article-title":"Association of Viral Suppression with Lower AIDS-defining and non-AIDS-defining Cancer incidence in HIV-infected veterans: a prospective cohort study","volume":"169","author":"Park","year":"2018","journal-title":"Ann Intern Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jss.2018.09.021","article-title":"Cancer registration in resource-limited environments-experience in Lagos","volume":"235","author":"Fatunmbi","year":"2019","journal-title":"Niger J Surg Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"13092","DOI":"10.1038\/s41598-025-97482-6","article-title":"Regional differences in the disease burden and attributable risk factors of female cancers","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hed.27639","article-title":"Population-based analysis of the human development index and risk factors for head and neck cancer","volume":"46","author":"Chien","year":"2024","journal-title":"Head Neck"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1933709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:51Z","timestamp":1789018311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1933709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":63,"alternative-id":["10.3389\/fpubh.2026.1933709"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1933709","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1933709"}}